Former Merck Analyst Shared Merger Tips, Faces Insider Trading Charges

Oct 16, 2014

Reuters

Federal prosecutors have charged Zachary Zwerko, former senior finance analyst at Merck, with conspiracy to commit fraud for tipping a contact about potential mergers, including Merck's takeover of Idenix Pharmaceuticals.

According to the complaint, Zwerko had access to a computer directory of information about potential acquisitions and learned Ardea and ViroPharma were both potential targets, and then passed the information via phone to trader at an unnamed bank. The bank trader, who is not being charged, allegedly traded on Zwerko's tips about Idenix, Ardea Biosciences and ViroPharma Inc.

Read the Reuters press release

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments